Skip to content

BIOCEPT, INC.

CIK 0001044378

← back to feed
Revenue (TTM)
$8.09M
−57.8% YoY Q2 Aug 2023
Net Income (TTM)
−$30.94M
−1,036.2% YoY Q2 Aug 2023
EPS Diluted (TTM)
−$5.10
−894.7% YoY Q2 Aug 2023
Gross Margin
-30.7%
Q2 Aug 2023
Operating Margin
-411.2%
Q2 Aug 2023
Net Margin
-382.6%
Q2 Aug 2023
Free Cash Flow (TTM)
−$12.48M
Q2 Aug 2023
Cash
$678.86K
Q2 Aug 2023
Total Debt
—
Q2 Aug 2023
Shares Outstanding
2.63M sh
Q2 Aug 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings